CoreCap Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$59.8K	Buy	+11,820	New	+$59.8K	﹤0.01%	1169
2024 Q2	–	Sell	-26	Closed	-$259	–	2401
2024 Q1	$259	Buy	+26	New	+$259	﹤0.01%	2391